Skip to main content
Print Download
Ovarian Cancer
Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal
Read More
Ovarian Cancer, PARP Inhibitors
Immunologic Response to COVID-19 Vaccination in Patients with Ovarian Cancer Receiving PARP Inhibitors
Read More
Ovarian Cancer
Intervention of a Health Education Clinical Nursing Pathway Among Patients with Ovarian Carcinoma
Read More
Ovarian Cancer
Implementation of a Collaborative Model Provides Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer
Read More
Ovarian Cancer
Assessing Comprehensive Care Deficits in US Ovarian Cancer Programs to Inform Quality Improvement Initiatives
Read More
Ovarian Cancer
2021 in Review
Read More
Ovarian Cancer
Cost-Effectiveness Analysis of Olaparib and Niraparib as Maintenance Therapy for Women with Recurrent Platinum-Sensitive Ovarian Cancer
Read More
Ovarian Cancer
Phase 2 Placebo-Controlled Study to Assess the Efficacy/Safety of Farletuzumab plus Chemotherapy in Women with Low CA-125 Platinum-Sensitive Ovarian Cancer
Read More
Ovarian Cancer
Phase 2 APPROVE Trial of Apatinib plus Pegylated Liposomal Doxorubicin (PLD) versus PLD for Platinum-Resistant Recurrent Ovarian Cancer
Read More
Ovarian Cancer
Long-Term Safety and Secondary Efficacy End Points in the ENGOT-OV16/NOVA Phase 3 Trial of Niraparib in Recurrent Ovarian Cancer
Read More
Page 2 of 3
Results 11 - 20 of 30